MEDICAL BW DEFENSE DOCTRINE FOR OPERATION DESERT SHIELD

File: 120396_sep96_decls80_0001.txt
Page: 0001
Total Pages: 3

Subject: MEDICAL BW DEFENSE DOCTRINE FOR OPERATION DESERT SHIELD         

Unit: OTSG        

Parent Organization: HSC         

Box ID: BX003203

Folder Title: MEDICAL BIOLOGICAL WARFARE DEFENSIVE DOCTRINE                                                   

Document Number:          1

Folder SEQ  #:         17




                                                      UNCLASSIFIED



                                                           6 Dec 9(:)

             MEDICAL BIOLOGICAL WARFARE (BW) DEFENSIVE DOCTRINE
                         FOR OPERATION DESERT SHIELD
   1. The primary defensive measures against all forms of BW agents
   are individual protection and collective protection.

   2. The best pre-enposure protection is immunization. For
   Operation Desert Shield it is critical that service members (SM) be
   vaccinated with anthrax vaccine and bOtLtlinLtm tc)xoid.
       Lacking pre-expOSLtr-e protection by vaccination, use of
   antibiotics and/or antitoxin in conjunction with immunization
   (either primary or booster) against known exposure to BW agents
   remains best method of treatment post-L-@,@posure. Upon exposure to
   anthrax or botulinum toxin, SM will be treated immediately with
   antibiotics/vaccine and antitoxin, respectively.

   4. Anthrax


       a. Pre-E.,@posure Vaccination

           (1) The anthrax vaccine (0.5 ml doses) is given at day
   zero, then second and fourth week with a booster at six months.
   For Operation Desert Shield the modified series is given at day 4)
   and at the second week. Protective levels of antibody against
   anthrax will be established two weeks after the second
   vaccination.

           (2) Immunization priority will be based on CINCCENT
   guidance, and will ge given to units considered at highest risk for
   exposure.

       b. Post-Exposure Treatment

           (1) All SM will be issued a blister pacp: of ten
   Ciprofloxacin tablets (500 mg) with instructions to take one tablet
   every 12 hours. The decision to begin taking the antibiotic will
   be made by the tactical commander based on confirmation of exposure
   or high probability of exposure. The tactical commander will be
   advised by his Intelligence Officer, Surgeon, and Chemical
   Officer. Other indicators of a BW attack are warning from the few
 at selected sites and the NBC
   Reporting System.


                           DECLASSIFIED
                           ON: 31 OCT 96
                           BY: SEC ARMY (DAMH) UNDER SEC 3.4 EO 12958






                                                    UNCLASSIFIED

Document 3 f:/Week-36/BX003203/MEDICAL BIOLOGICAL WARFARE DEFENSIVE DOCTRINE/medical bw defense doctrine for operation desert:11259610132420
Control Fields 17
File Room = sep96_declassified
File Cabinet = Week-36
Box ID = BX003203
Unit = OTSG
Parent Organization = HSC
Folder Title = MEDICAL BIOLOGICAL WARFARE DEFENSIVE DOCTRINE
Folder Seq # = 17
Subject = MEDICAL BW DEFENSE DOCTRINE FOR OPERATION DESERT
Document Seq # = 1
Document Date =
Scan Date =
Queued for Declassification = 01-JAN-1980
Short Term Referral = 01-JAN-1980
Long Term Referral = 01-JAN-1980
Permanent Referral = 01-JAN-1980
Non-Health Related Document = 01-JAN-1980
Declassified = 25-NOV-1996